Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs

BRIDGEWATER, N.J., Dec. 15 /PRNewswire-FirstCall/ — Sanofi-aventis U.S., an affiliate of sanofi-aventis, one of the world’s leading pharmaceutical companies, announced today that starting January 1, 2009, it has increased access to its non-oncology Patient Assistance Programs (PAP)s to include eligible uninsured patients with incomes up to 250% of the Federal Poverty Level.

These PAPs assist patients with limited financial resources in gaining access to needed sanofi-aventis U.S. prescription medicines by focusing on individual patients and acting as a resource for those patients and their advocates. Uninsured individuals with income levels of up to $26,000 and uninsured families of four with combined income of up to $53,000 may be eligible to receive sanofi-aventis U.S. prescription drugs at no charge through the expanded U.S. Traditional PAP.*

“Sanofi-aventis U.S. remains committed to making our prescription medicines available to uninsured and low income patients through our PAPs,” stated Greg Irace, President and CEO of sanofi-aventis U.S. “We have taken several steps to help patients with the greatest financial need access these medications.”

The sanofi-aventis U.S. Patient Assistance Programs include medicines for many different disease states, including: Diabetes, Rheumatoid Arthritis, Urology, Dermatology, Blood Clotting (Deep Vein Thrombosis, Pulmonary Embolism), and Allergies. For more information, please contact the sanofi-aventis U.S. Traditional PAP at 1-800-221-4025.

PACT+(R) (Providing Access to Cancer Therapy), is Sanofi-aventis U.S.’s PAP for Cancer medications. PACT+ provides access to our oncology brands for eligible low income patients with an income of no greater than 500 percent of the Federal Poverty Level. PACT+ also provides reimbursement support services plus offers help in identifying a variety of alternative services and resources to support the specific needs of cancer patients. For more information on PACT+, please call 1-800-996-6626.

In addition, sanofi-aventis U.S. is a proud participant in The Partnership for Prescription Assistance which brings together America’s pharmaceutical companies, doctors, other health care providers, patient advocacy organizations and community groups to help qualifying patients who lack prescription coverage get the medicines they need through the public or private program that’s right for them. Call 1-888-477-2669 or visit www.pparx.org.

*Federal Poverty Limits change annually and are issued by the US Department of Health and Human Services.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information, visit: www.sanofi-aventis.us or www.sanofi-aventis.com

Contact: Marc Greene, sanofi-aventis, 212-551-4780

SOURCE sanofi-aventis